Arcuro Medical is developing an all-suture, “all-inside” meniscus repair system.
Arcuro Medical’s novel approach is based on a technique in which the entire procedure is performed inside the joint space using suture material only and requiring just one entry into the joint. Arcuro’s proprietary SuperBall repair system consists of a knotless all-suture anchor and innovative delivery system for a meniscus repair that is secure, safe, reliable, and effective.
Stage: Business development
Founded: December 2013
Investor: The Trendlines Group
IP: National phase registered
Located in the knee joint, the delicate meniscus is a C-shaped cartilage that acts as a shock absorber and “cushions” the knee. Meniscus tears can be found in professional athletes, and as much as 60% of the population over age 65.
To maintain functionality, current practice is moving away from surgical removal of the meniscus toward arthroscopic repair techniques. Shortcomings of current repair devices, however, include rigid implants and difficult-to-use delivery systems that lead to poor repair quality, increased intraoperative failure, long-term damage to the meniscus, device failures, and the inability to repair all areas of the meniscus.
Worldwide, there are more than 300,000 meniscus repair procedures performed yearly, with a CAGR exceeding 10%. At an average device price per procedure of $800, the worldwide market reaches $240 million. Leading players include: Smith & Nephew, DePuy Synthes Mitek, Conmed, Arthrex, Covidien, Biomet.
Watch the product animation.
See the company 1-page description in Chinese (PDF).
Watch the product animation (Chinese).
See the presentation in Chinese (PDF).
Arcuro CEO Lee Ranon presents at a Trendlines Road Show event in the United States.
Lee Ranon, CEO
Portable, automatic system for peritoneal dialysis
Device for treating ischemic stroke
Anastomotic closure device for laparoscopic bowel resection
Miniature screwless spine fusion implant
Noninvasive monitoring for the diagnosis of heart failure